September 29, 2016
- Developing the biosimilar, from the bare bones of the drug, through production, to formulation
- Biosimilars and IP
- Regulatory requirements for biosimilars across the world
- Setting prices and evaluating the safety and efficacy of biosimilars
- The role of biobetters–improved versions of biosimilars
Event details available here.